Shots: Gilead to acquire 49.9% stakes in Pionyr for $275M and get an exclusive option to acquire the remaining shares. Gilead may exercise its option upon completion of P-Ib studies […]readmore
Tags : Holds
Shots: The hold of the project is in response to the insufficient consistency in measurements between tear glucose and blood glucose levels for evaluation of device Glucose-Detecting Contact Lens was […]readmore